Discoidin domain receptor 1a (DDR1a) confers 5-fluorouracil cytotoxicity in LoVo cell via PI3K/AKT/Bcl-2 pathway

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249.
   PubMed Web of Science ®Google Scholar
• Vértessy BG, Tóth J. Keeping uracil out of DNA: physiological role, structure and catalytic mechanism of dUTPases. Acc Chem Res. 2009;42(1):97–106.
   PubMed Web of Science ®Google Scholar
• Vodenkova S, Buchler T, Cervena K, et al. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future. Pharmacol Ther. 2020;206:107447.
   PubMed Web of Science ®Google Scholar
• Ongusaha PP, J-i K, Fang L, et al. p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop. EMBO J. 2003;22:1289–1301.
   PubMed Web of Science ®Google Scholar
• Leitinger B. Discoidin domain receptor functions in physiological and pathological conditions. Int Rev Cell Mol Biol. 2014;310:39–87.
   PubMed Web of Science ®Google Scholar
• Rammal H, Saby C, Magnien K, et al. Discoidin domain receptors: potential actors and targets in cancer. Front Pharmacol. 2016;7:55.
   PubMed Web of Science ®Google Scholar
• Ambrogio C, Gómez-López G, Falcone M, et al. Combined inhibition of DDR1 and notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma. Nat Med. 2016;22:270–277.
   PubMed Web of Science ®Google Scholar
• Xie R, Wang X, Qi G, et al. DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition. Tumour Biol. 2016;37:12049–12059.
   PubMedGoogle Scholar
• Bonfil RD, Chen W, Vranic S, et al. Expression and subcellular localization of discoidin domain receptor 1 (DDR1) define prostate cancer aggressiveness. Cancer Cell Int. 2021;21:507.
   PubMed Web of Science ®Google Scholar
• Nakada M, Kita D, Teng L, et al. Receptor tyrosine kinases: principles and functions in glioma invasion. Adv Exp Med Biol. 2020;1202:151–178.
   PubMed Web of Science ®Google Scholar
• Lin Y, Jin H, Wu X, et al. The cross-talk between DDR1 and STAT3 promotes the development of hepatocellular carcinoma. Aging (Albany NY). 2020;12:14391–14405.
   PubMedGoogle Scholar
• Vogel W, Gish GD, Alves F, et al. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell. 1997;1:13–23.
   PubMed Web of Science ®Google Scholar
• Vogel W. Discoidin domain receptors: structural relations and functional implications. FASEB J. 1999;13:S77–S82.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lan X, Wang Y, et al. CRNDE mediates the viability and epithelial-mesenchymal transition of renal cell carcinoma via miR-136-5p. J Recept Signal Transduct Res. 2021;41:234–244.
   PubMed Web of Science ®Google Scholar
• Küper A, Baumann J, Göpelt K, et al. Overcoming hypoxia-induced resistance of pancreatic and lung tumor cells by disrupting the PERK-NRF2-HIF-axis. Cell Death Dis. 2021;12:82.
   PubMed Web of Science ®Google Scholar
• Li S, Ren X, Wang Y, et al. Fucoxanthin alleviates palmitate-induced inflammation in RAW 264.7 cells through improving lipid metabolism and attenuating mitochondrial dysfunction. Food Funct. 2020;11:3361–3370.
   PubMed Web of Science ®Google Scholar
• Hardestam J, Klingström J, Mattsson K, et al. HFRS causing hantaviruses do not induce apoptosis in confluent Vero E6 and A-549 cells. J Med Virol. 2005;76:234–240.
   PubMed Web of Science ®Google Scholar
• Zhuang C, Ni S, Yang Z-C, et al. Oxidative stress induces chondrocyte apoptosis through caspase-dependent and caspase-independent mitochondrial pathways and the antioxidant mechanism of angelica sinensis polysaccharide. Oxid Med Cell Longev. 2020;2020:3240820.
   PubMed Web of Science ®Google Scholar
• Xie X, Xiao Y, Huang X. Homeobox C10 knockdown suppresses cell proliferation and promotes cell apoptosis in osteosarcoma cells through regulating caspase 3. Onco Targets Ther. 2018;11:473–482.
   PubMed Web of Science ®Google Scholar
• Pillai-Kastoori L, Schutz-Geschwender AR, Harford JA. A systematic approach to quantitative western blot analysis. Anal Biochem. 2020;593:113608.
   PubMed Web of Science ®Google Scholar
• Yang SH, Baek HA, Lee HJ, et al. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas. Oncol Rep. 2010;24:311–319.
   PubMed Web of Science ®Google Scholar
• Quan J, Yahata T, Adachi S, et al. Identification of receptor tyrosine kinase, discoidin domain receptor 1 (DDR1), as a potential biomarker for serous ovarian cancer. Int J Mol Sci. 2011;12:971–982.
   PubMed Web of Science ®Google Scholar
• He Y, Wang J, Wang J, et al. MicroRNA-135b regulates apoptosis and chemoresistance in colorectal cancer by targeting large tumor suppressor kinase 2. Am J Cancer Res. 2015;5:1382–1395.
   PubMed Web of Science ®Google Scholar
• Umar A, Boyer JC, Thomas DC, et al. Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability. J Biol Chem. 1994;269:14367–14370.
   PubMed Web of Science ®Google Scholar
• Shibata D, Peinado MA, Ionov Y, et al. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nat Genet. 1994;6:273–281.
   PubMed Web of Science ®Google Scholar
• Baguley BC. Classical and targeted anticancer drugs: an appraisal of mechanisms of multidrug resistance. Methods Mol Biol. 2016;1395:19–37.
   PubMedGoogle Scholar
• Narayanankutty A. PI3K/ Akt/ mTOR pathway as a therapeutic target for colorectal cancer: a review of preclinical and clinical evidence. Curr Drug Targets. 2019;20:1217–1226.
   PubMed Web of Science ®Google Scholar
• Cheng X, Xu X, Chen D, et al. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer. Biomed Pharmacother. 2019;110:473–481.
   PubMed Web of Science ®Google Scholar
• Chappell WH, Candido S, Abrams SL, et al. Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines. Aging (Albany NY). 2020;12:10194–10210.
   PubMedGoogle Scholar
• Shariati M, Evans KW, Zheng X, et al. Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations. Oncogene. 2021;40:4425–4439.
   PubMed Web of Science ®Google Scholar
• Xia C, Liu C, He Z, et al. Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression. J Exp Clin Cancer Res. 2020;39:127.
   PubMed Web of Science ®Google Scholar
• Belfiore A, Malaguarnera R, Nicolosi ML, et al. A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer. Cell Adh Migr. 2018;12:305–314.
   PubMed Web of Science ®Google Scholar